CDK5 downregulation enhances synaptic plasticity

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Cyclin-dependent kinase 5 (CDK5) is crucial for brain function, but its dysregulation is linked to cognitive deficits.
• Previous research suggests CDK5 inhibition offers neuroprotection.
• The role of CDK5 in neuroplasticity, including synaptic plasticity and dendritic morphogenesis, is debated.

Purpose of the Study:

• To investigate the role of CDK5 in synaptic plasticity and dendritic morphogenesis.
• To determine if CDK5 downregulation enhances neuroplasticity in mature neurons and mouse models.

Main Methods:

• Utilized shRNA-mediated CDK5 knockdown in wild-type and APPswe/PS1Δ9 transgenic mice.
• Administered CDK5 shRNA-miR via CA1 injections in mice.
• Cultured mature hippocampal neurons and applied CDK5 shRNA-miR for 12 days.
• Assessed long-term potentiation (LTP), paired-pulse facilitation (PPF), dendritic protrusion, Rac activity, BDNF expression, and signaling pathway activation (CaMKII, ERK, CREB).

Main Results:

• CDK5 knockdown increased LTP and restored PPF in a mouse model of Alzheimer's disease.
• Silencing CDK5 in mature hippocampal neurons promoted dendritic protrusion morphogenesis, dependent on Rac activity.
• CDK5 downregulation led to increased BDNF expression, transient phosphorylation of CaMKII, ERK, and CREB, and enhanced neurite calcium signaling.

Conclusions:

• CDK5 downregulation promotes synaptic plasticity in mature neurons.
• The observed effects involve calcium (Ca2+) signaling and activation of the BDNF/CREB pathway.
• Targeting CDK5 represents a potential therapeutic strategy for cognitive deficits and neurodegenerative diseases.